Abstract
A number of important studies at the 6th Conference on Retroviruses and Opportunistic Infections addressed using antiretroviral therapy in treatment-experienced patients. The growing availability of resistance assays and the expanding list of antiretroviral drugs make therapy both more complex and more effective. Results are presented from studies with nucleoside-experienced patients and protease inhibitor-experienced patients. The role of intensification is discussed and three definitions of that approach are explained. The use of resistance testing in guiding and modifying therapy is also discussed.
Original language | English (US) |
---|---|
Journal | The Hopkins HIV report : a bimonthly newsletter for healthcare providers / Johns Hopkins University AIDS Service |
Volume | 11 |
Issue number | 2 |
State | Published - 1999 |
Externally published | Yes |